Autolus Therapeutics Ltd (AUTL) stock news · rev $75.4M
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
This AUTL news page leads with what Autolus Therapeutics Ltd filed — not a scraped headline mill.
No cached 8-K sentence for AUTL yet. We will not pad this page with generic market recap.
Latest reported AUTL revenue for 2025-12-31 was $75.4M. Net income was -$287.5M. Revenue was up 644.9% from 2024-12-31 to 2025-12-31. AUTL currently screens at market cap $614.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AUTL stock page; for the tape open the quote page.
AUTL stock news FAQ
What are AUTL's latest revenue and net income?
Latest cached Autolus Therapeutics Ltd (AUTL) revenue for Dec 31, 2025 was $75.4M. Net income was -$287.5M. Statements: https://lician.com/financials/autl
How did AUTL revenue change from the prior cached period?
Cached Autolus Therapeutics Ltd (AUTL) revenue was up 644.9% from $10.1M (Dec 31, 2024) to $75.4M (Dec 31, 2025). Statements: https://lician.com/financials/autl
What is AUTL's market cap?
Autolus Therapeutics Ltd (AUTL) market cap is $614.8M on the latest cached fundamentals snapshot.
What kind of company is AUTL?
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Where is AUTL stock news listed?
Cached stock news for Autolus Therapeutics Ltd (AUTL) is listed at https://lician.com/news/autl. Filings: https://lician.com/sec/autl
Not investment advice.